Cite
HARVARD Citation
Schuler, E. et al. (n.d.). 120 RESULTS OF THE MULTICENTER, PHASE II STUDY OF THE SAFETY OF LENALIDOMIDE MONOTHERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) ASSOCIATED WITH AN ISOLATED DEL(5Q). Leukemia research. 39 (1), pp. S62-. [Online].